CAS: 1637443-98-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | hVEGF-IN-1 REF: AN-AG01DUA9CAS: 1637443-98-1 | >98% | To inquire | Tue 21 May 24 |
 | hVEGF-IN-1 REF: TM-T4288CAS: 1637443-98-1 | 98.85% | 94.00 €~2,004.00 € | Tue 28 May 24 |
 | hVEGF-IN-1 REF: 3D-MQC44398CAS: 1637443-98-1 | Min. 95% | To inquire | Tue 02 Jul 24 |
Ref: AN-AG01DUA9
| 1mg | 181.00 € | |
| 5mg | 574.00 € | |
| 10mg | 575.00 € | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 500mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
hVEGF-IN-1
CAS:1637443-98-1
hVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity.
Formula:
C34H43N7O2
Purity:
98.85%
Color and Shape:
Solid
Molecular weight:
581.75
Ref: TM-T4288
| 1mg | 94.00 € | |
| 5mg | 206.00 € | |
| 10mg | 291.00 € | |
| 25mg | 491.00 € | |
| 50mg | 711.00 € | |
| 100mg | 998.00 € | |
| 500mg | 2,004.00 € | |
| 1ml*10 (DMSO) | 267.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
hVEGF-IN-1
Controlled ProductCAS:1637443-98-1
hVEGF-IN-1 is a recombinant human vascular endothelial growth factor (VEGF) that has been shown to …
Formula:
C34H43N7O2
Purity:
Min. 95%
Molecular weight:
581.75 g/mol
Ref: 3D-MQC44398
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
